ASXL1 Mutations Associated With Worse Prognosis in MDS and AML
December 18th 2022A recent meta-analysis found ASXL1 mutations to be independent risk factors for worse overall survival and transformation to acute myeloid leukemia in patients with myelodysplastic syndromes (MDS), as well as worse overall survival in acute myeloid leukemia (AML).
Read More
T1D Community Helped Create T1D Index, Says JDRF's Tom Robinson
December 17th 2022Tom Robinson, vice president of global access at JDRF, talks about how the community and people living with type 1 diabetes (T1D) have contributed to the T1D Index, from development to publication and going forward.
Watch
ICYMI: Highlights From the 2022 American Academy of Dermatology Meeting
December 17th 2022This American Academy of Dermatology (AAD) Annual Meeting covered a breakthrough therapy for the management of vitiligo, clinical and epidemiological differences of certain dermatologic diseases, and the role of dietary triggers on patient outcomes.
Read More
Dr Patrick Reville Covers Study Results on Venetoclax Combined With CLIA
December 16th 2022Patrick Reville, MD, MPH, instructor, Department of Leukemia, MD Anderson Cancer Center, discusses findings on an updated treatment regimen for newly-diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome.
Watch
ICYMI: Top Content From DDW 2022
December 16th 2022Several therapeutic innovations in the management of Clostridioides difficile infection recurrence, current evidence on the efficacy of weight loss procedures in reversing nonalcoholic fatty liver disease, and an interview the use of artificial intelligence were spotlighted at Digestive Disease Week (DDW) 2022.
Read More
Greater Risk of Cataract Surgery Shown in Patients With Atopic Dermatitis, Allergic Diseases
December 16th 2022Korean patients with allergic diseases, including atopic dermatitis (AD), allergic rhinitis (AR), and asthma, had a higher risk of cataract surgery, and the combination of AD and AR resulted in the highest risk.
Read More
Managing GI Symptoms During OIT for Food Allergies
December 16th 2022Though a large proportion of patients receiving oral immunotherapy (OIT) for food allergy report gastrointestinal (GI) symptoms, a knowledge gap remains for the best approach to determine the underlying etiology and manage symptoms.
Read More
Dr Liz Lightstone: Lupus Nephritis Misconceptions Contributing to Underdiagnosis, Low-Value Care
December 15th 2022Liz Lightstone, MBBS, PhD, FRCP, professor of Renal Medicine for the Faculty of Medicine, Imperial College London, discussed how sexism and other factors cause certain symptoms of lupus nephritis to be overlooked, contributing to delays in diagnosis and care.
Watch
Conversations Around HIV PrEP With Adolescents Vary Between Urban, Rural Family Physicians
December 15th 2022This new study shows that family medicine physicians in rural areas tend to be less comfortable in HIV pre-exposure prophylaxis (PrEP)-related clinical activities and conversations with adolescents than those in urban areas.
Read More
COVID-19 vaccines have prevented more than 3.2 million deaths, but the US death rate this year has not declined to prepandemic numbers; Texas Attorney General (AG) Ken Paxton’s office has requested driver’s license records with sex changes from the past 2 years, among other documents, from the Texas Department of Public Safety; even though hepatitis C virus (HCV) is curable, some people who are incarcerated are going without treatment and dying.
Read More
ICYMI: Highlights From the 2022 AHA Scientific Sessions
December 15th 2022At this year’s American Heart Association (AHA) Scientific Sessions, held November 5-7 in Chicago, Illinois, hot topics for discussion included VICTORIA trial data and the great need for new antihypertensive agents to reduce health care disparities.
Read More
Modified Elimination Diet May Be Effective in Children With Eosinophilic Gastrointestinal Disorders
December 15th 2022Based on their retrospective findings, the researchers suggest the diet is a potentially effective option for these patients who may face challenges with other elimination diets.
Read More
Sleep Studies Needed to Confirm Subjective Improvement in OSA Symptoms After MAD Use
December 14th 2022Patients who used a mandibular advancement device (MAD) to address their obstructive sleep apnea (OSA) symptoms reported improvement in their sleep quality and tiredness on waking even if their sleep criteria did not indicate a response to treatment, indicating the importance of a posttreatment sleep study to ensure MAD efficacy.
Read More